Price Target Analysis of CBS Corporation(NYSE:CBS): ARCA biopharma, Inc.(NASDAQ:ABIO)

0
5

CBS Corporation (CBS) will report its next earnings on Aug 08 AMC. The company reported the earnings of $1.16/Share in the last quarter where the estimated EPS by analysts was $1.12/share. The difference between the expected and actual EPS was $0.04/share, which represents an Earnings surprise of 3.6%.

Many analysts are providing their Estimated Earnings analysis for CBS Corporation and for the current quarter 24 analysts have projected that the stock could give an Average Earnings estimate of $1.34/share. These analysts have also projected a Low Estimate of $1.29/share and a High Estimate of $1.47/share.

These analysts also forecasted Growth Estimates for the Current Quarter for CBS to be 8.1%. They are projecting Next Quarter growth of 5.33%. For the next 5 years, CBS Corporation is expecting Growth of 15.38% per annum, whereas in the past 5 years the growth was 5.59% per annum.

Some buy side analysts are also providing their Analysis on CBS Corporation, where 4 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for CBS Corporation might touch $70 high while the Average Price Target and Low price Target is $58.75 and $35 respectively.

CBS Corporation closed its last trading session at $43.63 with the gain of 1.1%. The Market Capitalization of the company stands at 16.36 Billion. The Company has 52-week high of $59.56 and 52-week low of $40.65. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.02% where SMA50 and SMA200 are -8.58% and -9.83% respectively. The Company Touched its 52-Week High on 11/02/18 and 52-Week Low on 09/03/19.

The Relative Volume of the company is 2.18 and Average Volume (3 months) is 3.16 million. The company’s P/E (price to earnings) ratio is 5.51 and Forward P/E ratio of 6.95.

The company shows its Return on Assets (ROA) value of 13.5%. The Return on Equity (ROE) value stands at 85.2%. While it’s Return on Investment (ROI) value is 18.8%.

While looking at the Stock’s Performance, CBS Corporation currently shows a Weekly Performance of 4.87%, where Monthly Performance is -13.2%, Quarterly performance is -8.05%, 6 Months performance is -10.13% and yearly performance percentage is -19.24%. Year to Date performance value (YTD perf) value is 0.89%. The Stock currently has a Weekly Volatility of 2.47% and Monthly Volatility of 2.94%.

ARCA biopharma, Inc. (ABIO) will report its next earnings on Aug 15 AMC. The company reported the earnings of $-1.14/Share in the last quarter where the estimated EPS by analysts was $-1.86/share. The difference between the expected and actual EPS was $0.72/share, which represents an Earnings surprise of 38.7%.

Many analysts are providing their Estimated Earnings analysis for ARCA biopharma, Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-1.3/share. These analysts have also projected a Low Estimate of $-1.3/share and a High Estimate of $-1.3/share.

Some buy side analysts are also providing their Analysis on ARCA biopharma, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for ARCA biopharma, Inc. might touch $9 high while the Average Price Target and Low price Target is $9 and $9 respectively.

ARCA biopharma, Inc. closed its last trading session at $5.36 with the gain of 3.92%. The Market Capitalization of the company stands at 7.91 Million. The Company has 52-week high of $20.45 and 52-week low of $4.72. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.84% where SMA50 and SMA200 are -11.49% and -23.5% respectively. The Company Touched its 52-Week High on 05/02/19 and 52-Week Low on 12/28/18.

The Relative Volume of the company is 0.49 and Average Volume (3 months) is 77.31 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -72.2%. The Return on Equity (ROE) value stands at -82.4%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, ARCA biopharma, Inc. currently shows a Weekly Performance of -0.89%, where Monthly Performance is -7.17%, Quarterly performance is -14.57%, 6 Months performance is -27.45% and yearly performance percentage is -47.77%. Year to Date performance value (YTD perf) value is -7.21%. The Stock currently has a Weekly Volatility of 6.94% and Monthly Volatility of 7.87%.

SHARE